OPC-14523 hydrochloride 是一种具有口服活性的sigma和5-HT1A受体激动剂,对 sigma 受体 (σ1/2IC50=47/56 nM)、5-HT1A 受体 (IC50=2.3 nM) 和 5-HT 转运体 (IC50=80 nM) 具有高度亲和力。OPC-14523 hydrochloride 显示抗抑郁药样活性。
生物活性 | OPC-14523 hydrochloride is an orally activesigmaand5-HT1A receptoragonist, with high affinity for sigma receptors (σ1/2IC50=47/56 nM), the 5-HT1A receptor (IC50=2.3 nM), and the 5-HT transporter (IC50=80 nM). OPC-14523 hydrochloride shows antidepressant-like activity[1][2]. |
IC50& Target[1] | 5-HT1AReceptor 2.3 nM (IC50) | sigma 1 47 nM (IC50) | sigma 2 56 mM (IC50) |
|
体外研究 (In Vitro) | OPC-14523 hydrochloride inhibits the in vitro reuptake of 3 H-5-HT (IC50=27 nM), but it shows very weak inhibitory activity on3H-NE and3H-DA reuptake[1].
|
体内研究 (In Vivo) | OPC-14523 hydrochloride (0.3-100 mg/kg; p.o.; daily for 0, 2, 4, 7 days) produces a marked antidepressant-like effect in the forced swimming test (FST) with rats and mice without affecting the general locomotor activity[1].
Animal Model: | Wistar strain of rats (140-245 g)[1] | Dosage: | 0.3-100 mg/kg | Administration: | P.o.; daily for 0, 2, 4, 7 days | Result: | A single doses of 1 mg/kg and higher of OPC-14523 reduced immobility time in the FST with an ED50value of 27 mg/kg. The ED50value for OPC-14523 on day 7 was 18 mg/kg. |
Animal Model: | ICR strain of mice (25-45 g)[1] | Dosage: | 0.3-100 mg/kg | Administration: | P.o.; daily for 0, 2, 4, 7 days | Result: | A single oral dose of OPC-14523 produced a marked reduction in immobility time during the FST at oral doses of 1 mg/kg and higher, with an ED50value of 20 mg/kg. The potency of OPC-14523 in decreasing immobility time was greater after treatment for seven consecutive days, producing an ED50 value of 2 mg/kg. |
|
分子量 | |
性状 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
溶解性数据 | In Vitro: DMSO : 83.33 mg/mL(185.01 mM;Need ultrasonic) H2O : 5 mg/mL(11.10 mM;ultrasonic and warming and heat to 60℃) 配制储备液 1 mM | 2.2202 mL | 11.1012 mL | 22.2025 mL | 5 mM | 0.4440 mL | 2.2202 mL | 4.4405 mL | 10 mM | 0.2220 mL | 1.1101 mL | 2.2202 mL |
*请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百 分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 1. 请依序添加每种溶剂: 10% DMSO 40%PEG300 5%Tween-80 45% saline Solubility: ≥ 2.08 mg/mL (4.62 mM); Clear solution
此方案可获得 ≥ 2.08 mg/mL (4.62 mM,饱和度未知) 的澄清溶液。 以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。 2. 请依序添加每种溶剂: 10% DMSO 90% (20%SBE-β-CDin saline) Solubility: ≥ 2.08 mg/mL (4.62 mM); Clear solution
此方案可获得 ≥ 2.08 mg/mL (4.62 mM,饱和度未知) 的澄清溶液。 以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。 3. 请依序添加每种溶剂: 10% DMSO 90%corn oil Solubility: ≥ 2.08 mg/mL (4.62 mM); Clear solution
此方案可获得 ≥ 2.08 mg/mL (4.62 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。 以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。 *以上所有助溶剂都可在本网站选购。
|